Why Champion Iron, Dusk, Hipages, and Imugene shares are charging higher

These ASX shares are on fire on Friday…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is rebounding strongly from recent declines. At the time of writing, the benchmark index is up 2.3% to 6,994.7 points.

Four ASX shares that are climbing more than most today are listed below. Here's why they are charging higher:

Concept image of a businessman riding a bull on an upwards arrow.

Image source: Getty Images

Champion Iron Ltd (ASX: CIA)

The Champion Iron share price is up 7% to $6.25. This follows a positive reaction to the iron ore producer's quarterly update from a number of brokers. One of those brokers is Citi. This morning the broker retained its buy rating and lifted its price target on the company's shares to $6.50. Citi was pleased with its quarterly update and has adjusted its estimates to reflect stronger iron ore prices.

Dusk Group Ltd (ASX: DSK)

The Dusk share price is up 14% to $2.70. Investors have been buying the retailer's shares following the release of a bullish broker note out of Shaw & Partners. According to the note, the broker has retained its buy rating and lifted its price target on the company's shares to $3.70.

Hipages Group Holdings Ltd (ASX: HPG)

The Hipages share price is up 7.5% to $3.00. Investors have been buying the tradie marketplace provider's shares after Goldman Sachs reaffirmed its buy rating on them following a disappointing quarterly update. The broker believes the soft quarter was a one-off due to COVID impacts and nothing structural. Goldman has a $3.60 price target on its shares.

Imugene Limited (ASX: IMU)

The Imugene share price is up 9% to 31.2 cents following the receipt of a patent. According to the release, the immuno-oncology company has received a notice of grant from the European Patent Office for its HER-Vaxx immunotherapy. This is currently in development for HER-2 positive gastric cancer.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Hipages Group Holdings Ltd. The Motley Fool Australia owns and has recommended Hipages Group Holdings Ltd. The Motley Fool Australia has recommended Dusk Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Five young people sit in a row having fun and interacting with their mobile phones.
Share Gainers

The five best ASX 200 stocks to buy and hold in April revealed

If you held these five ASX 200 stocks in April, you’ll be laughing today.

Read more »

Excited group of friends watching sports on TV and celebrating.
Share Gainers

Why these ASX shares jumped 15%+ in April

These shares delivered the goods for investors in April. But why?

Read more »

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup.
Share Gainers

Here are the top 10 ASX 200 shares today

Another day, another loss for investors.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Capstone Copper, Gentrack, Mineral Resources, and WiseTech shares are racing higher today

These shares are avoiding the market weakness and pushing higher. Let's find out why.

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Healthcare Shares

Guess which ASX All Ords healthcare share is rocketing 18% in Thursday's sinking market

Investors are piling into the ASX healthcare share on Thursday. But why?

Read more »

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another rough day for the markets this Wednesday.

Read more »

people looking through comical glasses, what to look for, reporting season, person thinking, person interested
Share Gainers

Are APA shares a buy after reaching a three-year high?

Can the share price keep storming higher in 2026?

Read more »

A service station attendant crosses his arms and smiles towards the camera with a backdrop of petrol bowsers and a drive-through facility.
Energy Shares

Ampol shares surge 50% to a two-year high: Buy, sell or hold?

Find out what upside analysts are tipping for Ampol shares next.

Read more »